XRAY Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Diversified Recurring Revenue ModelThe broad portfolio serves multiple dental disciplines and combines repeat-use consumables with equipment, software, service, and implant-related demand. This mix can support customer retention and recurring purchases while reducing reliance on any single product category over the next several quarters.
Positive Cash GenerationPositive operating cash flow in every period shown, alongside $131 million of trailing free cash flow, indicates the business continues to fund itself internally despite reported losses. This provides capacity for operations, investment, and debt obligations while the turnaround progresses.
Wellspect Product-led GrowthWellspect's growth was supported by new products, geographic expansion, and continued adoption rather than a temporary financial item. That combination offers evidence that targeted innovation and commercial execution can create durable growth within selected parts of the portfolio.
Bears Say
Persistent Revenue ContractionThe repeated revenue declines indicate that top-line pressure is broader than a single quarter and remains a central turnaround challenge. Sustained contraction can reduce operating leverage, limit reinvestment capacity, and make it harder for the company to convert its broad portfolio into consistent growth.
Ongoing UnprofitabilityPersistent net losses weaken earnings quality and reduce the cushion available to absorb operating setbacks. Although gross margin remains near 50% and losses have narrowed from earlier periods, profitability has not yet become durable enough to support stronger financial flexibility.
Elevated LeverageHigher leverage leaves less balance-sheet flexibility while revenue and earnings remain under pressure. Debt of approximately $2.3 billion relative to equity of $1.35 billion can constrain capital allocation and make sustained improvement in cash generation more important to financial stability.
DENTSPLY SIRONA News
XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
Currently, no data Available
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $35.39B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Oct 29, 2026 which is in 45 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Aug 06, 2026. The company reported $8.813 earnings per share for the quarter, beating the consensus estimate of $5.898 by $2.915.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc does not currently pay dividends.
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 5.39.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 199,353,880 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of $8.813 in its last earnings report, beating expectations of $5.898. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in MX:XRAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$232.73 (― Upside)
$232.73 (― Upside)
Blogger Sentiment
Neutral
MX:XRAY Sentiment 75%
Sector Average 61%
Sector Average 61%
Insider Transactions
Bought Shares
Worth $8.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.87%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
XRAY Company Deck
XRAY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflected a mixed but constructive tone: management reported near-term top-line pressures across multiple segments (notably OIS and consumables distributor headwinds in EMEA) and acknowledged tariff and geopolitical uncertainties. Offsetting these challenges were stable adjusted EBITDA and EPS, a one-time $44 million tariff refund that materially improved cash flow and EPS, continued strategic investments in sales, clinical education and R&D, expansion of dealer partnerships, and strong Wellspect performance. Management maintained full-year guidance and emphasized that improvements from the return-to-growth action plan should become more visible in Q4 and into 2027. Given balanced operational progress and strategic momentum against ongoing revenue and regional demand headwinds, the overall message is cautiously optimistic but still in turnaround mode.View all MX:XRAY earnings summariesXRAY Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
